Renal Dialysis Market Research Report Information By Type of Dialysis (Primary Dialysis and Secondary Dialysis), By Dialysis Products (Dialysis Machines, Dialyzers, Dialysis Concentrates, Dialysis Catheters, and Others), By End Users (Hospitals, Dialysis Centers, and Home Care Settings), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030

Global Renal Dialysis Market Overview

Renal Dialysis Market Size was valued at USD 99.2 billion in 2022 and is projected to grow from USD 107.63 Billion in 2023 to USD 175.59 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.50% during the forecast period (2023 - 2030). Growing demand for peritoneal dialysis and an increase in the incidence of renal diseases are the key market drivers enhancing the market growth.

  Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Renal Dialysis Market Trends

• Rising incidence of renal diseases to surge the market growth

Chronic kidney disease (CKD) causes kidney damage, which may eventually make them less effective at removing waste products from the blood than healthy kidneys. Ineffective kidneys cause the body to accumulate toxic waste and extra fluid, which can cause high blood pressure, heart disease, stroke, and early death. However, those who have CKD or are at risk for developing it can take precautions to safeguard their kidneys with the assistance of their medical professionals.

According to the CDC, the number of Americans with CKD is estimated to be higher than one in seven, or 15% of 37 million adults US citizens. One study found that up to 90% of adults with CKD are unaware of their condition. Most adults with severe CKD are unaware of their condition, about 2 in 5 cases. Compared to those aged 45–64 (12%) and 18–44 (6%), people 65 years of age and older (38%) have a higher prevalence of CKD. Women (14%) and men (12%) are slightly more likely to have CKD. CKD affects non-Hispanic Black adults more frequently (16%) than non-Hispanic White adults (13%) or non-Hispanic Asian adults (13%). One in every fourteen adult Hispanics has CKD. Thus the growing prevalence of kidney disease and the rising geriatric population are a factor driving the growth of the Renal Dialysis market revenue

Figure 1: Percentage of US Adults Aged 18 Years or Older With CKD

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

The government globally is taking initiatives to create awareness regarding kidney diseases. The CDC created the Chronic Kidney Disease (CKD) Initiative in 2006 to offer public health strategies for promoting kidney health. The CDC established the CKD Surveillance System in cooperation with the University of California at San Francisco and the University of Michigan to track the development of efforts to prevent, detect, and manage CKD and document CKD and its risk factors in the US population over time. Among them are the Healthy People objectives for kidney disease. In collaboration with other federal agencies, universities, and non-profit organizations, CDC publishes Chronic Kidney Disease in the United States to provide information to the public, kidney health advocates, and researchers on CKD prevalence, health consequences, risk factors, and prevention and treatment strategies. Moreover, the Pradhan Mantri National Dialysis Programme (PMNDP) was introduced in 2016 to offer free dialysis services to all patients in district hospitals in India who fall under the BPL. Therefore, such government initiatives are expected to propel the Renal Dialysis market CAGR during the forecast period.

Renal Dialysis Market Segment Insights

Renal Dialysis Type of Dialysis Insights

The Renal Dialysis Market segmentation, based on the type of dialysis, includes Primary Dialysis and Secondary Dialysis. The Primary Dialysis segment held the majority share in 2022 in the Renal Dialysis Market revenue. The demand for hemodialysis is being driven by the clinical advantages of this procedure, including the shorter procedure time and adoption of the arteriovenous fistula (AV Fistula). On a global scale, the epidemic has significantly increased the demand for renal replacement fluids. If COVID-19 patients are compared to previous US populations, RRT is now five times more necessary. (4.9 percent as of 2020 VS. 0.9 percent earlier).

Renal Dialysis Product Insights

The Renal Dialysis Market segmentation, based on dialysis products, includes dialysis machines, dialyzers, dialysis concentrates, dialysis catheters, and others. The dialysis machines segment dominated the market in 2022. This results from technological development, rising kidney disease prevalence, including end-stage renal disease (ESRD), and an increased number of novel product market players are launching. Such factors positively impact the renal dialysis market growth.

January 2019: Fresenius Medical Care launched the 4008A dialysis machine, specifically created to meet the needs of emerging markets.  The company wants to make it easier for patients in these nations with end-stage renal disease to access life-sustaining dialysis treatment with the introduction of the 4008A. (ESRD).

Figure 3: Renal Dialysis Market, by Dialysis Products, 2022 & 2030 (USD Million)

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Renal Dialysis End User Insights

The end-user has bifurcated the Renal Dialysis Market data into hospitals, dialysis centers, and home care settings. The dialysis segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. Dialysis centers significantly contribute to the global dialysis market because patients typically prefer to receive their treatments there. The potential for growth of the home dialysis market is increased because patients' awareness of home dialysis is continually increasing along with their demand for at-home healthcare.

Renal Dialysis Regional Insights

By Region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North America Renal Dialysis market accounted for USD 45.4 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period. The major factors expected to drive the market's expansion during the forecast period include the high prevalence of CKD and ESRD in the U.S. and Canada and higher treatment rates in these nations. Due to the rising number of coronavirus infections and the ensuing renal failures, the U.S. is also expected to see growth in the demand for services and products.

Further, the major countries studied in the market report are: The U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: RENAL DIALYSIS MARKET SHARE BY REGION 2022 (%)

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Europe Renal Dialysis market accounts for the second-largest market share in 2022. The region's rising geriatric population, the prevalence of renal diseases, and the rise in expenditure are the main causes of the high market growth. Further, the Germany Renal Dialysis market held the largest market share, and the UK Renal Dialysis market was the fastest-growing market in the European region

The Asia-Pacific Renal Dialysis Market is expected to grow at the fastest CAGR from 2022 to 2030. Funding from public players to increase access to renal care will likely accelerate market growth. The market expansion in Asia-Pacific is anticipated to be aided by the region's established regulatory framework for renal treatment facilities during the forecast period. Moreover, the China Renal Dialysis market held the largest market share, and the India Renal Dialysis market was the fastest-growing market in the Asia-Pacific region

Renal Dialysis Key Market Players & Competitive Insights

Major market players are investing in the R&D of various products that are advanced and low-cost. Market participants frequently use inorganic strategic alliances, such as partnerships, acquisitions, and capacity expansions, in addition to investments, to strengthen their market positions and gain competitive advantages. Competitors in the Renal Dialysis industry must offer cost-effective items to survive in an increasingly competitive environment.

One of the key strategies manufacturers adopt in the global Renal Dialysis industry is launching new products in the market. In recent years, the Renal Dialysis industry has been collaborating with other companies in the market. The Renal Dialysis market major player such as Baxter (US), Fresenius Medical Care AG & Co. KGaA (Germany), B. Braun Melsungen AG (Germany), Becton Dickinson and Company (US), Nipro (Japan), Medtronic (Ireland), Nikkiso Co. Ltd (Japan), Asahi Kasei Medical Co. Ltd (Japan), and Cantel Medical (US), and others are working on expanding the market demand by investing in research and development activities.

Medtronic is a company that provides solutions for the most complex and difficult conditions in the healthcare industry. The company has a presence in more than 150 countries.  In December 2020, Medtronic Inc. commercially launched a pediatric emergency dialysis device. It is designed to treat AKI or fluid overload patients weighing between 5.5 and 22 pounds.

Baxter is based in Deerfield, Illinois. The company's main focus areas are kidney disease treatments and other chronic and urgent medical conditions. In May 2017, Baxter International Inc., a leader in the field of renal care, introduced a new iteration of its AK 98 hemodialysis (HD) system that includes two-way IT connectivity, the ability to accommodate patients of lower weights, and features that make treatment setup easier and shorten downtime in between sessions.

Key Companies in the Renal Dialysis market include

• Baxter (US)


• Fresenius Medical Care AG & Co. KGaA (Germany)


• Braun Melsungen AG (Germany)


• Becton Dickinson and Company (US)


• Nipro (Japan)


• Medtronic (Ireland)


• Nikkiso Co. Ltd (Japan)


• Asahi Kasei Medical Co. Ltd (Japan)


• Cantel Medical (US), among others

Renal Dialysis Industry Developments

March 2022 The SURDIAL DX Hemodialysis System was introduced in the US by Nipro Medical Corporation, a producer and distributor of renal, vascular, and medical-surgical products.

March 2021 The Rekha Memorial Renny Abraham Ambattur Rotary TANKER Foundation Subsidized Dialysis Unit at Ambattur has donated a dialysis machine from the RANE Group.

Renal Dialysis Market Segmentation

Renal Dialysis Type of Dialysis Outlook

• Primary Dialysis


• Secondary Dialysis

Renal Dialysis Products Outlook

• Dialysis Machines


• Dialyzers


• Dialysis Concentrates


• Dialysis Catheters


• Others

Renal Dialysis End User Outlook

• Hospitals


• Dialysis Centers


• Home Care Settings

Renal Dialysis Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America